GLN

10.0%

11.3¢ galan lithium limited

@HOOPZ what’s the latest on the various short positions? Do MS...

First 9122 Last

Share
Profile

Follow
spovend

2,604 Posts.

1303

21/10/22

22:25

Post #: 64331443
Share

Originally posted by HOOPZ: ↑

I keep the history... We had a little bit of an increase in shorting on the 26th (234k on the daily short report which was 11% of all trade) which will show up on the cumulative ASIC report sometime tomorrow (which is what you see on shortman). Only a portion of this 234k will make it through as some will have been covered on the same day - but probably most of it will come through. These reports are not perfect but their accuracy is good enough (i.e. data issues might persist for one to two days but tend to be resolved pretty quickly).

I suspect it was Morgan Stanley, yet again, as they just happen to have an increase in selling volume on the same day.

I noticed that they seem to have done a little bit of short covering as we moved up to $1.50 - but not a lot. Interesting that they chose to add to their shorts at $1.20 rather than at $1.50 which might mean that it's either not a high conviction strategy or perhaps it's just a hedge. Though it wasn't put on like a hedge (i.e. the price was moving up when they put on their 1.8m short position well after the July low).

Anyway, nothing to worry about - just a point of interest really. Almost everything is getting shorted to some extent in this market. It's only a concern when it starts moving above 1% of SOI.

ALL IMO DYOR

Expand

@HOOPZ what’s the latest on the various short positions? Do MS still have 1.7million or whatever it was?

GLN Price at posting: $1.27 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RXL

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 6,817 more messages in this thread...

First 9122 Last

Add GLN (ASX) to my watchlist

(20min delay)
Last 11.3¢		Change -0.013(10.0%)		Mkt cap ! $67.05M

Open	High	Low	Value	Volume
12.0¢	12.0¢	11.0¢	$43.57K	371.7K

Buyers (Bids)

No.	Vol.	Price($)
31	1565493	11.0¢

Sellers (Offers)

Price($)	Vol.	No.
11.5¢	131309	10

View Market Depth

No.	Vol.	Price($)
28	1547668	0.110
28	2290085	0.105
61	3593142	0.100
5	181111	0.099
2	350000	0.098

Price($)	Vol.	No.
0.115	131309	10
0.120	188891	8
0.125	499453	12
0.130	500900	13
0.135	1108914	5

Last trade - 10.52am 04/10/2024 (20 minute delay)

GLN (ASX) Chart

@HOOPZ what’s the latest on the various short positions? Do MS...

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

@HOOPZ what’s the latest on the various short positions? Do MS...

Top Stories

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News